Stocklytics Platform
Nanobiotix S.A.
NBTX52
$3.30arrow_drop_up0.17%$0.00
NASDAQ - As of Apr 24, 9:05 PM EDT Market Closed
Penny Stock
NBTX52

$3.30

arrow_drop_up0.17%

Performance History

Chart placeholder
Key Stats
Open$3.33
Prev. Close$3.29
EPS-0.78
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$155.96M
PE Ratio-
LOWHIGH
Day Range3.25
3.35
52 Week Range2.11
9.17

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$859.73
Perf. (24h)arrow_drop_up3.92%$32.53
Market Cap$772.18B
Price$424.25
Perf. (24h)arrow_drop_down0.70%-$3.00
Market Cap$415.38B
Price$154.93
Perf. (24h)arrow_drop_down0.28%-$0.44
Market Cap$370.89B
Price$180.37
Perf. (24h)arrow_drop_up3.47%$6.15
Market Cap$306.01B

About Nanobiotix S.A. (NBTX)

Nanobiotix S.A. (NBTX) is a biotechnology company that specializes in the development of nanomedicine for the treatment of cancer. The company's flagship product, NBTXR3, is a first-in-class nanoparticle designed to enhance the efficacy of radiation therapy. NBTXR3 is currently being evaluated in multiple clinical trials across various cancer indications. Nanobiotix's innovative approach to cancer treatment has garnered significant attention from the medical community and investors alike. The company's stock price history reflects this excitement, with steady growth over the past several years. As of the latest quote, NBTX is trading at a favorable price, indicating a positive market sentiment towards the company's future prospects.
In addition to its promising product pipeline, Nanobiotix has also been praised for its strong financial position. The company has a healthy market cap, which demonstrates the market's confidence in its ability to deliver on its goals. Nanobiotix's financial success can also be attributed to its efficient use of capital and its solid revenue growth. The company's smart analysis further supports its positive outlook, as it highlights the favorable industry trends that Nanobiotix is well-positioned to capitalize on. Comparing NBTX to its industry peers, the company stands out as a leader in innovation and potential for long-term growth.
Show more
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Laurent Levy Ph.D.
Headquarters
Paris
Employees
102
Exchange
NASDAQ
add Nanobiotix S.A. to watchlist

Keep an eye on Nanobiotix S.A.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Nanobiotix S.A.'s (NBTX) price per share?

The current price per share for Nanobiotix S.A. (NBTX) is $3.3. The stock has seen a price change of $0.01 recently, indicating a 0.18% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Nanobiotix S.A. (NBTX)?

For Nanobiotix S.A. (NBTX), the 52-week high is $9.18, which is 178.06% from the current price. The 52-week low is $2.11, the current price is 56.4% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Nanobiotix S.A. (NBTX) a growth stock?

Nanobiotix S.A. (NBTX) has shown an average price growth of -1.65% over the past three years. It has received a score of 43 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Nanobiotix S.A. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Nanobiotix S.A. (NBTX) stock price performance year to date (YTD)?

As of the latest data, Nanobiotix S.A. (NBTX) has a year-to-date price change of 14.98%. Over the past month, the stock has experienced a price change of -9.54%. Over the last three months, the change has been 2.8%. Over the past six months, the figure is -33.47%.
help

Is Nanobiotix S.A. (NBTX) a profitable company?

Nanobiotix S.A. (NBTX) has a net income of -$39.7M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -253.32% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $36.21M, although specific revenue growth data is currently not available. The gross profit is $36.21M. Operating income is noted at -$26.78M. Furthermore, the EBITDA is -$23.22M.
help

What is the market capitalization of Nanobiotix S.A. (NBTX)?

Nanobiotix S.A. (NBTX) has a market capitalization of $155.96M. The average daily trading volume is 3.29, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level